Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

radiochemistry

  • You have access
    Molecular Imaging in Cancer Chemoresistance: What’s Brewing?
    Luca Urso, Licia Uccelli, Alessandra Boschi, Orazio Schillaci and Luca Filippi
    Journal of Nuclear Medicine March 1, 2025, 66 (3) 344-348; DOI: https://doi.org/10.2967/jnumed.124.268967
  • Development of a <sup>213</sup>Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates
    You have access
    Development of a 213Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates
    Aidan A. Bender, Emily K. Kirkeby, Donna J. Cross, Satoshi Minoshima, Andrew G. Roberts and Tara E. Mastren
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1467-1472; DOI: https://doi.org/10.2967/jnumed.124.267482
  • First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging
    Open Access
    First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging
    Richard Laforest, Anchal Ghai, Tyler J. Fraum, Reiko Oyama, Jennifer Frye, Helen Kaemmerer, Greg Gaehle, Tom Voller, Cedric Mpoy, Buck E. Rogers, Mark Fiala, Kooresh I. Shoghi, Samuel Achilefu, Michael Rettig, Ravi Vij, John F. DiPersio, Sally Schwarz, Monica Shokeen and Farrokh Dehdashti
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 320-328; DOI: https://doi.org/10.2967/jnumed.122.264349
  • Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
    Open Access
    Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
    Allen F. Brooks, Wade P. Winton, Jenelle Stauff, Janna Arteaga, Bradford Henderson, Jeremy Niedbala, Peter J.H. Scott and Benjamin L. Viglianti
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1949-1955; DOI: https://doi.org/10.2967/jnumed.122.263864
  • You have access
    Proceedings: PET Drugs—A Workshop on Inspections Management and Regulatory Considerations
    Sue Bunning, Christopher Ignace, Steve Mattmuller, Sally W. Schwarz, Peter J.H. Scott, Henry F. VanBrocklin, Steven S. Zigler and on behalf of the Coalition of Drug Manufacturers
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1117-1123; DOI: https://doi.org/10.2967/jnumed.121.263443
  • You have access
    FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?
    Rodney J. Hicks, Peter J. Roselt, Kumarswamy G. Kallur, Richard W. Tothill and Linda Mileshkin
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 296-302; DOI: https://doi.org/10.2967/jnumed.120.256271
  • Open Access
    68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
    Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha and Shaojun Zhu
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 149-155; DOI: https://doi.org/10.2967/jnumed.120.260455
  • Synthesis of the PET Tracer <sup>124</sup>I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
    You have access
    Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
    Edwin C. Pratt, Elizabeth Isaac, Evan P. Stater, Guangbin Yang, Ouathek Ouerfelli, Nagavarakishore Pillarsetty and Jan Grimm
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1845-1850; DOI: https://doi.org/10.2967/jnumed.120.241901
  • You have access
    Production of 15O for Medical Applications via the 16O(γ,n)15O Reaction
    Stacy L. Queern, Ryan Cardman, Christopher S. Loveless, Matthew R. Shepherd and Suzanne E. Lapi
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 424-428; DOI: https://doi.org/10.2967/jnumed.118.215681
  • You have access
    α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2
    Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis
    Journal of Nuclear Medicine July 1, 2018, 59 (7) 1020-1027; DOI: https://doi.org/10.2967/jnumed.117.204651

Pages

  • Next
  • 1
  • 2
SNMMI

© 2025 SNMMI

Powered by HighWire